loading

Cardiol Therapeutics Inc Aktie (CRDL) Neueste Nachrichten

pulisher
07:11 AM

Cardiol Therapeutics announces $13.5M bought-deal private placement - MSN

07:11 AM
pulisher
Feb 13, 2026

Aug Drivers: Is Cardiol Therapeutics Inc stock risky to hold nowRecession Risk & Safe Capital Growth Trade Ideas - baoquankhu1.vn

Feb 13, 2026
pulisher
Feb 12, 2026

Why Cardiol Therapeutics Inc. stock remains resilientWeekly Investment Summary & AI Driven Stock Price Forecasts - mfd.ru

Feb 12, 2026
pulisher
Feb 12, 2026

Is Cardiol Therapeutics Inc. a momentum stockWeekly Profit Report & Safe Capital Growth Plans - mfd.ru

Feb 12, 2026
pulisher
Feb 11, 2026

(CRDL) Financial Trading Report (CRDL:CA) - Stock Traders Daily

Feb 11, 2026
pulisher
Feb 11, 2026

Fundamentals Check: Can Cardiol Therapeutics Inc maintain its current growth rateJobs Report & Expert Approved Momentum Ideas - baoquankhu1.vn

Feb 11, 2026
pulisher
Feb 11, 2026

Can Cardiol Therapeutics Inc generate free cash flow2025 Price Action Summary & Daily Stock Trend Watchlist - baoquankhu1.vn

Feb 11, 2026
pulisher
Feb 10, 2026

CRDL Stock Rating Reiterated at 'Buy' by HC Wainwright & Co. | C - GuruFocus

Feb 10, 2026
pulisher
Feb 10, 2026

Cardiol Therapeutics (NASDAQ:CRDL) Receives "Buy" Rating from HC Wainwright - MarketBeat

Feb 10, 2026
pulisher
Feb 10, 2026

Cardiol Therapeutics Inc. - Baystreet.ca

Feb 10, 2026
pulisher
Feb 10, 2026

Cardiol Therapeutics publishes phase II myocarditis study results - Investing.com

Feb 10, 2026
pulisher
Feb 10, 2026

Cardiol Therapeutics’ ARCHER Phase II Myocarditis Data Published in ESC Heart Failure - TipRanks

Feb 10, 2026
pulisher
Feb 10, 2026

Cardiol Therapeutics' ARCHER Phase II Study Results Published in ESC Heart Failure - Investing News Network

Feb 10, 2026
pulisher
Feb 10, 2026

Cardiol Therapeutics publishes phase II myocarditis study results By Investing.com - Investing.com India

Feb 10, 2026
pulisher
Feb 09, 2026

How the (CRDL) price action is used to our Advantage (CRDL:CA) - Stock Traders Daily

Feb 09, 2026
pulisher
Feb 06, 2026

Equities Analysts Set Expectations for CRDL FY2025 Earnings - MarketBeat

Feb 06, 2026
pulisher
Feb 06, 2026

Cardiol Therapeutics (NASDAQ:CRDL) Stock Rating Upgraded by Brookline Cap M - MarketBeat

Feb 06, 2026
pulisher
Feb 06, 2026

Analysts Offer Predictions for CRDL FY2025 Earnings - MarketBeat

Feb 06, 2026
pulisher
Feb 06, 2026

Cardiol Therapeutics (TSE:CRDL) Shares Down 7.1% – Time to Sell? - Defense World

Feb 06, 2026
pulisher
Feb 06, 2026

Cardiol Therapeutics (TSE:CRDL) Shares Down 7.1%Time to Sell? - MarketBeat

Feb 06, 2026
pulisher
Feb 06, 2026

Cardiol Therapeutics (NASDAQ:CRDL) Upgraded at Brookline Capital Management - Defense World

Feb 06, 2026
pulisher
Feb 05, 2026

Cardiol Therapeutics (NASDAQ:CRDL) Raised to Strong-Buy at Brookline Capital Management - MarketBeat

Feb 05, 2026
pulisher
Feb 03, 2026

(CRDL) Market Dynamics and Trading Signals (CRDL:CA) - Stock Traders Daily

Feb 03, 2026
pulisher
Feb 02, 2026

Cardiol Therapeutics files underwriting agreement and warrant indenture By Investing.com - Investing.com Nigeria

Feb 02, 2026
pulisher
Feb 02, 2026

Cardiol Therapeutics files underwriting agreement and warrant indenture - Investing.com

Feb 02, 2026
pulisher
Feb 02, 2026

Cardiol Therapeutics Secures $14.85 Million Bought-Deal Unit Financing - TipRanks

Feb 02, 2026
pulisher
Feb 01, 2026

Targets Report: Can Cardiol Therapeutics Inc weather a recessionPortfolio Profit Report & Daily Growth Stock Tips - baoquankhu1.vn

Feb 01, 2026
pulisher
Jan 29, 2026

Fund Flows: Will Ambarella Inc stock benefit from M A2025 Trading Volume Trends & Safe Swing Trade Setups - baoquankhu1.vn

Jan 29, 2026
pulisher
Jan 29, 2026

Aug Retail: Is MPWR in a bullish channel2025 Volatility Report & Daily Entry Point Trade Alerts - baoquankhu1.vn

Jan 29, 2026
pulisher
Jan 28, 2026

(CRDL) Strategic Equity Report (CRDL:CA) - Stock Traders Daily

Jan 28, 2026
pulisher
Jan 28, 2026

Can Cardiol Therapeutics Inc. weather a recessionJuly 2025 Analyst Calls & Verified Technical Trade Signals - mfd.ru

Jan 28, 2026
pulisher
Jan 26, 2026

Cardiol Therapeutics Secures U.S. Patent for Heart Drugs - MSN

Jan 26, 2026
pulisher
Jan 26, 2026

Cardiol Therapeutics Secures $13.5 Million Bought-Deal Financing to Advance Heart Disease Programs - TipRanks

Jan 26, 2026
pulisher
Jan 26, 2026

Cardiol Therapeutics Inc. Announces Bought Deal Financing for Gross Proceeds of $13.5 Million - Investing News Network

Jan 26, 2026
pulisher
Jan 26, 2026

Cardiol Therapeutics Announces Bought Deal Financing for Gross Proceeds of $13.5 Million - Investing News Network

Jan 26, 2026
pulisher
Jan 25, 2026

When the Price of (CRDL) Talks, People Listen (CRDL:CA) - Stock Traders Daily

Jan 25, 2026
pulisher
Jan 23, 2026

Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million - TMX Newsfile

Jan 23, 2026
pulisher
Jan 23, 2026

Cardiol Therapeutics Inc. announced that it has received CAD 13.500001 million in funding - marketscreener.com

Jan 23, 2026
pulisher
Jan 22, 2026

(CRDL) Equity Trading Insights (CRDL:CA) - Stock Traders Daily

Jan 22, 2026
pulisher
Jan 21, 2026

Top Canadian Stocks to Buy Right Away With $5,000 - Yahoo! Finance Canada

Jan 21, 2026
pulisher
Jan 20, 2026

Will Cardiol Therapeutics Inc. (CT9) stock gain from lower interest ratesChart Pattern Recognition & Free Discover Fast Growing Stocks - bollywoodhelpline.com

Jan 20, 2026
pulisher
Jan 20, 2026

Why Cardiol Therapeutics Inc. stock is favored by top institutionsCup and Handle Formations & Identify Breakout Stocks - bollywoodhelpline.com

Jan 20, 2026
pulisher
Jan 18, 2026

Portfolio Shifts: Will Cardiol Therapeutics Inc outperform tech stocksTake Profit & AI Enhanced Market Trend Forecasts - baoquankhu1.vn

Jan 18, 2026
pulisher
Jan 17, 2026

Cardiol Therapeutics announces $13.5 million private placement By Investing.com - Investing.com Nigeria

Jan 17, 2026
pulisher
Jan 17, 2026

(CRDL) Technical Pivots with Risk Controls (CRDL:CA) - Stock Traders Daily

Jan 17, 2026
pulisher
Jan 16, 2026

Cardiol Therapeutics announces $13.5 million bought deal financing By Investing.com - Investing.com Nigeria

Jan 16, 2026
pulisher
Jan 16, 2026

Cardiol Therapeutics Inc. announced that it expects to receive CAD 13.500001 million in funding - marketscreener.com

Jan 16, 2026
pulisher
Jan 16, 2026

Cardiol Therapeutics Secures $13.5 Million Bought Deal Financing to Advance Heart Disease Programs - TipRanks

Jan 16, 2026
pulisher
Jan 16, 2026

Cardiol Therapeutics announces $13.5 million private placement - Investing.com

Jan 16, 2026
pulisher
Jan 16, 2026

Cardiol Therapeutics announces $13.5 million bought deal financing - Investing.com

Jan 16, 2026
pulisher
Jan 16, 2026

Heart drug developer Cardiol lines up $13.5M to fund trials and research - Stock Titan

Jan 16, 2026
pulisher
Jan 16, 2026

AI Stocks: Is NeuroSense Therapeutics Ltd Equity Warrant forming a bullish divergenceJuly 2025 Fed Impact & AI Enhanced Trading Signals - baoquankhu1.vn

Jan 16, 2026
drug_manufacturers_specialty_generic RDY
$14.14
price down icon 1.19%
$124.12
price up icon 0.83%
$25.13
price up icon 1.37%
drug_manufacturers_specialty_generic RGC
$31.22
price up icon 7.58%
$15.77
price down icon 0.13%
$473.66
price down icon 0.52%
Kapitalisierung:     |  Volumen (24h):